方法文章

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

DOI:

10.3791/62226

2021年2月25日

* These authors contributed equally

本文内容

摘要

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Lipid nanoparticles are developed using a microfluidic mixing platform approach for mRNA and DNA encapsulation.

摘要

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Lipid-based drug carriers have been used for clinically and commercially available delivery systems due to their small size, biocompatibility, and high encapsulation efficiency. Use of lipid nanoparticles (LNPs) to encapsulate nucleic acids is advantageous to protect the RNA or DNA from degradation, while also promoting cellular uptake. LNPs often contain multiple lipid components including an ionizable lipid, helper lipid, cholesterol, and polyethylene glycol (PEG) conjugated lipid. LNPs can readily encapsulate nucleic acids due to the ionizable lipid presence, which at low pH is cationic and allows for complexation with negatively charged RNA or DNA. Here LNPs are formed by encapsulating messenger RNA (mRNA) or plasmid DNA (pDNA) using rapid mixing of the lipid components in an organic phase and the nucleic acid component in an aqueous phase. This mixing is performed using a precise microfluidic mixing platform, allowing for nanoparticle self-assembly while maintaining laminar flow. The hydrodynamic size and polydispersity are measured using dynamic light scattering (DLS). The effective surface charge on the LNP is determined by measuring the zeta potential. The encapsulation efficiency is characterized using a fluorescent dye to quantify entrapped nucleic acid. Representative results demonstrate the reproducibility of this method and the influence that different formulation and process parameters have on the developed LNPs.

引言

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Drug carriers are used to protect and deliver a therapeutic with typical favorable properties including low cytotoxicity, increased bioavailability, and improved stability1,2,3. Polymeric nanoparticles, micelles, and lipid-based particles have previously been explored for nucleic acid encapsulation and delivery4,5,6,7. Lipids have been used in different types of nanocarrier systems, including liposomes, and lipid nanoparticles, as they are biocompat....

访问受限。请登录或开始试用以查看此内容。

方案

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

A schematic of the overall process is provided in Figure 1.

1. Preparation of buffers

NOTE: Sterile filtering of the buffers is highly suggested here to remove any particulates which may impact the nucleic acid and LNP quality.

  1. Phosphate Buffered Saline (PBS)
    1. Prepare 1x PBS using 8 mM Na2HPO4, 2 mM KH2PO4, 137 mM NaCl, and 2.7 mM KCl in nuclease free water and adjust the pH to 7.4.
    2. Sterilize by vacuum filtration using a 0.22 µm pore-size filter.
  2. Citrate Buffer
    1. Prepare ci....

访问受限。请登录或开始试用以查看此内容。

结果

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Multiple batches of LNPs with the same lipid formulation and N/P ratio of 6 were developed on separate days to demonstrate reproducibility of the technique. Batch 1 and 2 resulted in overlapping size distributions with similar polydispersity (Figure 2A) No significant difference was observed in the size or encapsulation efficiency between the two different batches (Figure 2B). The encapsulation efficiency was high for each batch .......

访问受限。请登录或开始试用以查看此内容。

讨论

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Reproducibility, speed, and low volume screening are significant advantages of using microfluidic mixing to form LNPs compared to other existing methods (e.g., lipid film hydration and ethanol injection). We have demonstrated the reproducibility of this method with no impact on encapsulation efficiency or particle size observed with different LNP batches. This is an essential criterion for any therapeutic, including LNPs, to become clinically available.

The technique described here employs sta.......

访问受限。请登录或开始试用以查看此内容。

披露

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

All authors are employees of Sanofi. The authors declare that they have no conflict of interest or competing financial interests.

致谢

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Thank you to Atul Saluja, Yatin Gokarn, Maria-Teresa Peracchia, Walter Schwenger, and Philip Zakas for their guidance and contributions towards LNP development.

....

访问受限。请登录或开始试用以查看此内容。

材料

本文使用的材料清单
姓名公司目录编号评论
1,2-二肉豆蔻酰-rac-甘油-3-甲氧基聚乙二醇-2000 (C-14 PEG)Avanti 极性脂质880151P
10 µl 渐变滤镜提示 (无 RNase、DNase、DNA)美国科学1121-3810
1000 µl 刻度过滤头(无 RNase-,DNase-, DNA)USA Scientific1111-2831
20 µl 斜面滤芯吸头(不含 RNase-,DNase-, DNA)USA Scientific1120-1810
200 µl 刻度滤芯吸头(无RNase-,DNase-,DNA)美国科学公司1120-8810
3&β;-羟基-5-胆甾烯,5-胆甾-3&β;-醇(胆固醇)Sigma-AldrichC8667
BD滑头无菌注射器(1毫升注射器)Thermo Fisher Scientific14-823-434
BD滑头无菌注射器(3ml注射器)Thermo Fisher Scientific14-823-436
BD Vacutainer 通用注射器针头(BD 钝填充针 18G)Thermo Fisher Scientific23-021-020
台式离心机Beckman Coulter
黑色 96 孔板Thermo Fisher Scientific14-245-177
BrandTech 品牌 BIO-CERT 无 RNase、DNase、DNA 微量离心管 (1.5mL)Thermo Fisher Scientific14-380-813
柠檬酸Fisher Scientific02-002-611
康宁 500 毫升真空过滤器/储存瓶系统,0.22 um 孔径康宁430769
一次性折叠毛细管细胞马尔文DTS1070
乙醇,纯 200 标准Sigma-Aldrich459844
Fisher 品牌半微量比色皿Thermo FisherScientific14955127
Invitrogen 锥形管 (15 mL)(不含 DNase-RNase)Thermo Fisher ScientificAM12500
MilliporeSigma Amicon Ultra 离心过滤装置Thermo Fisher ScientificUFC901024
NanoAssemblr 台式精密 Nanyosystems
无核酸酶水Fisher ScientificAM9930
磷酸盐缓冲盐水 (PBS)Thermo Fisher ScientificAM9624
Quant-iT PicoGreen dsDNA 检测试剂盒Thermo Fisher Scientific P7589
Quant-iT RiboGreen RNA 检测试剂盒Thermo Fisher ScientificR11490
氯化钠Fisher Scientific02-004-036
柠檬酸钠,二水合物,颗粒状 Fisher Scientific02-004-056
SpectraMax i3xMolecular Devices
Zetasizer NanoMalvern
Thermo

参考文献

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,
  1. Mitchell, M. J., Billingsley, M. M., Haley, R. M., Wechsler, M. E., Peppas, N. A., Langer, R., et al. Engineering precision nanoparticles for drug delivery. Nature Reviews Drug Discovery. , 1-24 (2020).
  2. Davis, M. E., Chen, Z., Shin, D. M.

访问受限。请登录或开始试用以查看此内容。

重印与许可

申请许可以重复使用本 JoVE 文章的文本或图表

申请许可

标签

RNA DNA

相关文章